USD 0.24
(-0.49%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | -1.3 Million USD | -135.5% |
2023 | -555 Thousand USD | 5.61% |
2022 | -588 Thousand USD | -167.35% |
2021 | 873 Thousand USD | -37.2% |
2020 | 1.39 Million USD | -82.0% |
2019 | 7.72 Million USD | 20426.32% |
2018 | -38 Thousand USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -244 Thousand USD | 20.78% |
2024 Q4 | -513 Thousand USD | 24.95% |
2024 Q2 | -193 Thousand USD | 20.9% |
2024 Q3 | -683.5 Thousand USD | -254.15% |
2024 FY | -1.3 Million USD | -135.5% |
2023 Q2 | -179 Thousand USD | 25.1% |
2023 Q3 | -68 Thousand USD | 62.01% |
2023 Q4 | -308 Thousand USD | -352.94% |
2023 FY | -555 Thousand USD | 5.61% |
2023 Q1 | -239 Thousand USD | -19.5% |
2022 Q4 | -200 Thousand USD | -34.23% |
2022 Q2 | -120.51 Thousand USD | -1.72% |
2022 FY | -588 Thousand USD | -167.35% |
2022 Q1 | -118.48 Thousand USD | -181.36% |
2022 Q3 | -149 Thousand USD | -23.63% |
2021 Q4 | 145.62 Thousand USD | -2.26% |
2021 Q2 | 350 Thousand USD | 52.73% |
2021 Q3 | 149 Thousand USD | -57.43% |
2021 FY | 873 Thousand USD | -37.2% |
2021 Q1 | 229.16 Thousand USD | 216.12% |
2020 Q4 | -197.34 Thousand USD | -162.77% |
2020 FY | 1.39 Million USD | -82.0% |
2020 Q3 | 314.37 Thousand USD | -51.3% |
2020 Q2 | 645.6 Thousand USD | 2.89% |
2020 Q1 | 627.46 Thousand USD | -91.88% |
2019 Q1 | - USD | 0.0% |
2019 FY | 7.72 Million USD | 20426.32% |
2019 Q4 | 7.72 Million USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | -38 Thousand USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 2.55 Million USD | 151.255% |
BrainsWay Ltd. | 23.09 Million USD | 105.66% |
Cerus Corporation | 86.4 Million USD | 101.513% |
Envoy Medical, Inc. | -473 Thousand USD | -176.321% |
electroCore, Inc. | 13.22 Million USD | 109.882% |
Helius Medical Technologies, Inc. | 61 Thousand USD | 2242.623% |
IceCure Medical Ltd | 1.3 Million USD | 200.538% |
Inogen, Inc. | 126.69 Million USD | 101.032% |
OrthoPediatrics Corp. | 111.25 Million USD | 101.175% |
Lucid Diagnostics Inc. | -6.05 Million USD | 78.397% |
Monogram Orthopaedics, Inc. | -47.33 Thousand USD | -2661.112% |
MaxCyte, Inc. | 36.54 Million USD | 103.576% |
NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 386.298% |
Nexalin Technology, Inc. | 85.06 Thousand USD | 1636.562% |
Orthofix Medical Inc. | 486.27 Million USD | 100.269% |
PAVmed Inc | -3.96 Million USD | 67.061% |
Rapid Micro Biosystems, Inc. | -5.48 Million USD | 76.171% |
RxSight, Inc. | 53.76 Million USD | 102.431% |
Sight Sciences, Inc. | 69.17 Million USD | 101.889% |
SI-BONE, Inc. | 109.42 Million USD | 101.194% |
TELA Bio, Inc. | 40.11 Million USD | 103.258% |
Treace Medical Concepts, Inc. | 151.93 Million USD | 100.86% |
Vivos Therapeutics, Inc. | 8.27 Million USD | 115.802% |
Acutus Medical, Inc. | -3.13 Million USD | 58.336% |
Talis Biomedical Corporation | 371 Thousand USD | 452.291% |
Spectral AI, Inc. | 7.88 Million USD | 116.586% |
Nano-X Imaging Ltd. | -6.59 Million USD | 80.173% |
CVRx, Inc. | 33.03 Million USD | 103.956% |
DIH Holding US, Inc. Warrants | - USD | Infinity% |
PetVivo Holdings, Inc. | 739.52 Thousand USD | 276.735% |
Bioventus Inc. | 328.19 Million USD | 100.398% |
Venus Concept Inc. | 52.16 Million USD | 102.505% |
TriSalus Life Sciences, Inc. | 15.9 Million USD | 108.217% |
LivaNova PLC | 771.25 Million USD | 100.169% |
908 Devices Inc. | 25.32 Million USD | 105.162% |
Alphatec Holdings, Inc. | 310.2 Million USD | 100.421% |
Nemaura Medical Inc. | -1.47 Million USD | 11.473% |
NeuroPace, Inc. | 48.12 Million USD | 102.716% |
LENSAR, Inc. | 21.1 Million USD | 106.192% |
Apyx Medical Corporation | 14.12 Million USD | 109.255% |
Cutera, Inc. | 41.49 Million USD | 103.15% |
STRATA Skin Sciences, Inc. | 18.46 Million USD | 107.08% |
BioSig Technologies, Inc. | 18 Thousand USD | 7361.111% |
Anika Therapeutics, Inc. | 103.08 Million USD | 101.268% |
ClearPoint Neuro, Inc. | 13.61 Million USD | 109.6% |
Integra LifeSciences Holdings Corporation | 888.39 Million USD | 100.147% |
Axonics, Inc. | 274.55 Million USD | 100.476% |
Outset Medical, Inc. | 29 Million USD | 104.507% |
IRIDEX Corporation | 21.8 Million USD | 105.993% |
PROCEPT BioRobotics Corporation | 71.04 Million USD | 101.84% |
IRadimed Corporation | 50.15 Million USD | 102.606% |
Tivic Health Systems, Inc. | 287 Thousand USD | 555.401% |
INVO Bioscience, Inc. | 1.08 Million USD | 220.335% |
Telesis Bio, Inc. | 16.95 Million USD | 107.711% |
Viemed Healthcare, Inc. | 112.78 Million USD | 101.159% |
Varex Imaging Corporation | 256.9 Million USD | 100.509% |
Quipt Home Medical Corp. | 163.84 Million USD | 100.798% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | -221.921% |
Pulmonx Corporation | 50.75 Million USD | 102.575% |
Dynatronics Corporation | 7.63 Million USD | 117.119% |
Modular Medical, Inc. | -768 Thousand USD | -70.182% |
ReShape Lifesciences Inc. | 5.54 Million USD | 123.558% |
Semler Scientific, Inc. | 61.2 Million USD | 102.136% |
InMode Ltd. | 411.34 Million USD | 100.318% |
Bruker Corporation | 1.51 Billion USD | 100.086% |
Cytosorbents Corporation | 22.39 Million USD | 105.837% |
DexCom, Inc. | 2.28 Billion USD | 100.057% |
Align Technology, Inc. | 2.71 Billion USD | 100.048% |
Viveve Medical, Inc. | 620 Thousand USD | 310.806% |
ZimVie Inc. | 290.38 Million USD | 100.45% |
Movano Inc. | -158 Thousand USD | -727.215% |
Cytek Biosciences, Inc. | 109.42 Million USD | 101.194% |
Nexalin Technology, Inc. | 85.06 Thousand USD | 1636.562% |
DIH Holdings US, Inc. Class A Common Stock | - USD | Infinity% |
Tandem Diabetes Care, Inc. | 367.69 Million USD | 100.355% |
Profound Medical Corp. | 4.51 Million USD | 128.954% |
Insulet Corporation | 1.15 Billion USD | 100.113% |
enVVeno Medical Corporation | -546 Thousand USD | -139.377% |
Surmodics, Inc. | 93.05 Million USD | 101.405% |
iCAD, Inc. | 14.53 Million USD | 108.991% |
Nuwellis, Inc. | 4.98 Million USD | 126.229% |
Biotricity, Inc. | 8.35 Million USD | 115.641% |
iRhythm Technologies, Inc. | 331.8 Million USD | 100.394% |
Aethlon Medical, Inc. | -359.05 Thousand USD | -264.009% |
InspireMD, Inc. | 1.8 Million USD | 172.33% |
PAVmed Inc. | -3.96 Million USD | 67.061% |
BIOLASE, Inc. | 16.72 Million USD | 107.815% |
FONAR Corporation | 45.14 Million USD | 102.895% |
AxoGen, Inc. | 127.87 Million USD | 101.022% |
Vivani Medical, Inc. | -357 Thousand USD | -266.106% |
Tactile Systems Technology, Inc. | 195.13 Million USD | 100.67% |
Inari Medical, Inc. | 434.56 Million USD | 100.301% |
UFP Technologies, Inc. | 112.22 Million USD | 101.165% |
QT Imaging Holdings, Inc. | - USD | Infinity% |
Heart Test Laboratories, Inc. | 12.51 Thousand USD | 10540.131% |
Tenon Medical, Inc. | 1.24 Million USD | 205.318% |
Autonomix Medical, Inc. Common Stock | -81 Thousand USD | -1513.58% |
Co-Diagnostics, Inc. | 2.62 Million USD | 149.751% |
AdaptHealth Corp. | 479.56 Million USD | 100.273% |
Sintx Technologies, Inc. | 1.84 Million USD | 170.917% |
NanoVibronix, Inc. | 1.53 Million USD | 185.036% |
Quanterix Corporation | 70.64 Million USD | 101.85% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | -221.921% |
Sensus Healthcare, Inc. | 14.06 Million USD | 109.296% |
Pacific Biosciences of California, Inc. | 52.78 Million USD | 102.476% |
TransMedics Group, Inc. | 154.09 Million USD | 100.848% |
ReWalk Robotics Ltd. | 4.45 Million USD | 129.351% |
NeuroMetrix, Inc. | 3.94 Million USD | 133.11% |
Hyperfine, Inc. | 4.75 Million USD | 127.475% |
Establishment Labs Holdings Inc. | 106.97 Million USD | 101.222% |
Biomerica, Inc. | 611 Thousand USD | 313.912% |
Bone Biologics Corporation | - USD | Infinity% |
AVITA Medical, Inc. | 41.68 Million USD | 103.135% |
Bluejay Diagnostics, Inc. | -780.95 Thousand USD | -67.359% |
Silk Road Medical, Inc | 127.08 Million USD | 101.028% |